Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
1.84 Up 0.02(1.10%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 324   39   -   -  
Cost of Revenue -   -   -   -  
Gross Profit 324   39   -   -  
Operating Expenses
Research Development9,120  10,110  10,725  11,989  
Selling General and Administrative4,605  4,635  4,830  4,823  
Non Recurring1,988   -   -   -  
Others401  429  450  439  
Total Operating Expenses16,114   -   -   -  
Operating Income or Loss (15,790) (15,135) (16,005) (17,251)
Income from Continuing Operations
Total Other Income/Expenses Net61  553  665  (197)
Earnings Before Interest And Taxes(15,729)(14,582)(15,340)(17,448)
Interest Expense20  7  9  10  
Income Before Tax(15,749)(14,589)(15,349)(17,458)
Income Tax Expense(3,512) -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(12,237)(14,589)(15,349)(17,458)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (12,237) (14,589) (15,349) (17,458)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (12,237) (14,589) (15,349) (17,458)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.